NR3C2 and Obesity: These results shed new light on vascular mechanisms of obesity-associated cardiac dysfunction in premenopausal women and provide rationale for further study of MR inhibition and pathways downstream of SMC-MR as sex-specific strategies to treat cardiac and coronary dysfunction, critical contributors to development of HFpEF in obese women.